Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis

IncobotulinumtoxinA, a pure botulinumtoxinA formulation, is free of accessory proteins. This analysis provides pooled safety data from phase 3 trials of children/adolescents (2–17 years), investigating incobotulinumtoxinA for the treatment of spasticity associated with cerebral palsy (at doses ≤20 U...

Descripción completa

Detalles Bibliográficos

Autores principales:	Steffen Berweck, Marta Banach, Deborah Gaebler-Spira, Henry G. Chambers, A. S. Schroeder, Thorin L. Geister, Michael Althaus, Angelika Hanschmann, Matteo Vacchelli, Michaela V. Bonfert, Florian Heinen, Edward Dabrowski
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2022-08-01
Colección:	Toxins
Materias:	botulinum toxin incobotulinumtoxinA muscle spasticity all movement disorders all pediatric sialorrhea
Acceso en línea:	https://www.mdpi.com/2072-6651/14/9/585
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!